Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Piers EM Patten"'
Autor:
Christianne Bourlon, Claire Roddie, Tobias Menne, Jane Norman, Maeve O’Reilly, Adam Gibb, Caroline Besley, Sridhar Chaganti, Carlos Gonzalez Arias, Ceri Jones, Abdalla Dikair, Sharon Allen, Frances Seymour, Wendy Osborne, Amrith Mathew, William Townsend, Piers EM Patten, Eleni Thoulouli, Ahmed Abdulgawad, Sanne Lugthart, Robin Sanderson, Amy A Kirkwood, Andrea Kuhnl
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/b6135250d1674766ba4e7c30eb20df47
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
In chronic lymphocytic leukaemia (CLL), immune dysregulation is common and can manifest as immune thrombocytopenia (ITP). Corticosteroids are the mainstay for front-line management of CLL-associated ITP. Therapy refractoriness represents a clinical c
Externí odkaz:
https://doaj.org/article/a4a7699e92f24c6aacda9dabd5e5fc99
Autor:
John C. Byrd, Jennifer A. Woyach, Richard R. Furman, Peter Martin, Susan O'Brien, Jennifer R. Brown, Deborah M. Stephens, Jacqueline C. Barrientos, Piers EM Patten, Talha Munir, Krish Patel, Anna Butturini, Marianne de Borja, Min Hui Wang, Nitin Jain, William G. Wierda
Publikováno v:
Blood. 140:9865-9867
Autor:
Richard R. Furman, William G. Wierda, Anna Schuh, Piers EM Patten, Jorge M. Chaves, Jennifer R. Brown, Talha Munir, Peter Martin, Farrukh T. Awan, Deborah M. Stephens, Paolo Ghia, Jacqueline C. Barrientos, Krish Patel, Jennifer A. Woyach, Anna Butturini, Marianne de Borja, Min Hui Wang, Susan O'Brien, John C. Byrd
Publikováno v:
Blood. 140:9873-9875
Autor:
Anita Sarma, Piers Em Patten
Publikováno v:
Medicine. 49:286-292
Chronic lymphocytic leukaemia/small lymphocytic lymphoma is a common subtype of non-Hodgkin lymphoma that is often diagnosed after finding an incidental lymphocytosis on a routine blood count. Key diagnostic tests are peripheral blood morphology and
Autor:
Catherine Thieblemont, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A. Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I. Chen, Loretta J. Nastoupil, Bastian von Tresckow, Andrés José María Ferreri, Takanori Teshima, Piers EM Patten, Joseph P. McGuirk, Andreas Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Zinzani, Ram Malladi, Aiesha Zia, Chiara Lobetti Bodoni, Aisha Masood, Stephen J. Schuster, Nathan H. Fowler, Martin Dreyling
Publikováno v:
Transplantation and Cellular Therapy. 28:S63-S64
Autor:
Tobias Menne, Victoria T Potter, Irfan Kayani, M. Cuadrado, Maria A. V. Marzolini, Maeve A O'Reilly, Wendy Osborne, Piers Em Patten, Reuben Benjamin, Andrea Kuhnl, Nicola Mulholland, Claire Roddie, George Petrides, Amy A Kirkwood, Deborah Yallop, William Townsend, Stefan Vöö, Robin Sanderson
Publikováno v:
Blood Advances
Visual Abstract
Autor:
Leslie Popplewell, Charalambos Andreadis, Catherine Thieblemont, Andrés J.M. Ferreri, Hideo Harigae, Arne Kolstad, Phoebe Joy Ho, Fritz Offner, Aisha Masood, Ranjan Tiwari, Jie Zhang, Piers Em Patten, Jose Antonio Pérez Simón, L. J. Nastoupil, Kouji Kato, Stephen J. Schuster, M. Dreyling, Takanori Teshima, Ram Malladi, Andreas L. Petzer, Bastian von Tresckow, Monalisa Ghosh, Nathan Fowler, Joseph P. McGuirk, Peter A. Riedell, Joaquin Martinez-Lopez, Jason Butler, P. L. Zinzani, Andreas Viardot, Emmanuel Bachy, M. José Kersten, Michael Dickinson, Julio C. Chavez, Vamsi Bollu
Publikováno v:
Hematological Oncology. 39
Autor:
Wendy Osborne, Tobias Menne, Reuben Benjamin, Deborah Yallop, Nicola Mulholland, Victoria Potter, R. Sanderson, M. Cuadrado, Piers Em Patten, Andrea Kuhnl, George Petrides
Publikováno v:
Hematological Oncology. 39
Autor:
E. Alexander, Reuben Benjamin, J. Summers, M. Cuadrado, I. Vasiliadou, J.L. Brady, C. Gillham, Robin Sanderson, A. Kuhnl, O. Evans, Victoria Potter, N. Mikhaeel, Piers Em Patten, A. Bates, T. Ajithkumar
Publikováno v:
Radiotherapy and Oncology. 161:S241-S242
Purpose or Objective CD19 CAR-T therapy is the most effective salvage treatment for relapsed/refractory DLBCL. However the manufacture of CAR-T cells takes several weeks and patients (pts) are at risk of progression during this time and usually requi